Tandem Diabetes Care News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.01.24	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (Businesswire)
08.01.24	Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor (Businesswire)
12.12.23	Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers (Businesswire)
06.12.23	Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S. (Businesswire)
06.11.23	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
01.11.23	Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer (Businesswire)
24.08.23	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
03.08.23	Tandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi System (Businesswire)
01.08.23	Tandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023 (Businesswire)
11.07.23	Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance (Businesswire)
10.07.23	Tandem Diabetes Care to Announce Second Quarter 2023 Financial Results on August 3, 2023 (Businesswire)
24.05.23	Tandem Diabetes Care to Present at the Jefferies Healthcare Conference (Businesswire)
03.05.23	Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance (Businesswire)
20.04.23	Tandem Diabetes Care to Present at the BofA Securities 2023 Health Care Conference (Businesswire)
17.04.23	Tandem Diabetes Care Announces Control-IQ Technology Meta-analysis Demonstrating Positive Clinical Impact of Automatic Correction Bolusing on Glucose Control in People with Type 1 Diabetes (Businesswire)
11.04.23	Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023 (Businesswire)
15.03.23	Tandem Diabetes Care Announces NEJM Publication of Study Demonstrating Increased Time in Range in Young Children with Type 1 Diabetes Using the t:slim X2 Insulin Pump with Control-IQ Technology (Businesswire)
22.02.23	Tandem Diabetes Care Appoints New Chair of Board of Directors (Businesswire)
15.02.23	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
23.01.23	Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical (Businesswire)
19.01.23	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023 (Businesswire)
10.01.23	Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook (Businesswire)
03.01.23	Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference (Businesswire)
13.12.22	Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical (Businesswire)
16.11.22	Tandem Diabetes Care Earns Great Place to Work Certification™ (Businesswire)
10.11.22	Tandem Diabetes Care Study Demonstrates Improvements of All Clinical Endpoints in Adults with Type 2 Diabetes Using Control-IQ Technology (Businesswire)
08.11.22	Tandem Diabetes Care Announces Upcoming Conference Presentation (Businesswire)
02.11.22	Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
27.10.22	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
04.10.22	Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022 (Businesswire)
22.08.22	Tandem Diabetes Care Announces Upcoming Conference Presentations (Businesswire)
18.08.22	Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App (Businesswire)
03.08.22	Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
21.07.22	Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical (Businesswire)
12.07.22	Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022 (Businesswire)
16.06.22	Tandem Diabetes Care Welcomes Two New Members to Board of Directors (Businesswire)
06.06.22	Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes (Businesswire)
18.05.22	Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation (Businesswire)
04.05.22	Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance (Businesswire)
27.04.22	Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults (Businesswire)
11.04.22	Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022 (Businesswire)
07.03.22	Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation (Businesswire)
22.02.22	Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance (Businesswire)
16.02.22	Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App (Businesswire)
11.02.22	Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations (Businesswire)
19.01.22	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2021 Financial Results on February 22, 2022 (Businesswire)
02.12.21	Tandem Diabetes Care Announces Expansion of Senior Leadership Team (Businesswire)
28.06.21	Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations (Businesswire)
05.05.21	Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Tandem Diabetes Care Inc

Aktien Top/Flop

Meistgelesene Nachrichten